
Obsikon 37.5mg Tablet CR
Marketer
Ikon Pharmachem Pvt Ltd
Salt Composition
Paroxetine (37.5mg)
Overview Obsikon 37.5mg Tablet CR
Sertraline 37.5mg extended-release tablets are a selective serotonin reuptake inhibitor (SSRI) antidepressant. Frequently prescribed for depression and anxiety disorders such as obsessive-compulsive disorder and panic attacks, this medication helps many patients improve their mood and alleviate anxiety and tension, aiding in their recovery from depression. Administration is independent of food intake. Dosage and frequency are determined individually by your physician to optimize symptom control; initially, a lower dose may be prescribed, gradually increasing as needed. Never alter your dosage or discontinue treatment without consulting your doctor, as this may worsen your condition or trigger unpleasant withdrawal (including anxiety, agitation, rapid heartbeat, dizziness, sleep problems, etc.). For maximum efficacy, take this medication consistently at the same time daily; morning administration is recommended if sleep disturbances occur. Significant improvement may take several weeks. Report a lack of improvement after four weeks to your physician. Common side effects include nausea, tiredness, dry mouth, decreased appetite, increased perspiration, lightheadedness, nervousness, shaking, insomnia, and constipation. Reduced libido, delayed ejaculation, and erectile dysfunction are also potential side effects. Immediately report any sudden mood deterioration or suicidal thoughts. Before commencing treatment, inform your doctor of any pre-existing epilepsy, diabetes, liver or kidney problems, cardiovascular disease, or glaucoma, as these conditions may influence treatment. Pregnant or breastfeeding individuals must seek medical advice prior to use. Interactions may occur with other medications, particularly other antidepressants and MAO inhibitors; provide your doctor with a complete list of your current medications to ensure safety.
Primary Ingredients of Obsikon 37.5mg Tablet CR
No information provided. Please provide the text you wish me to rephrase.
Uses of Obsikon 37.5mg Tablet CR
Managing Depressive Symptoms | Addressing Panic Attacks | Anxiety Disorder Management
Major Benefits of Obsikon 37.5mg Tablet CR:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment schedule. Ingest the 37.5mg Obsikon CR tablet whole; avoid chewing, crushing, or fracturing it. Consumption with or without food is acceptable, although consistent daily timing is recommended.
Common Side effects of Obsikon 37.5mg Tablet CR:
- Nausea
- Fatigue
- Dryness in mouth
- Loss of appetite
- Increased sweating
- Dizziness
- Nervousness
- Tremors
- Low sexual desire
- Insomnia (difficulty in sleeping)
- Confusion
- Constipation
- Erectile dysfunction
- Delayed ejaculation
- Decreased libido
How to use Obsikon 37.5mg Tablet CR:
Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Obsikon 37.5mg Controlled-Release Tablets can be consumed with or without food, although consistent timing is recommended.
How Obsikon 37.5mg Tablet CR works:
Obsikon CR 37.5mg tablets are an antidepressant medication classified as a selective serotonin reuptake inhibitor (SSRI). Their mechanism of action involves elevating serotonin concentrations within the brain—a neurotransmitter crucial for mood regulation. Consequently, this leads to improvements in both the emotional and somatic manifestations of depression, offering relief from the symptoms of panic disorder, anxiety, and obsessive-compulsive disorder as well.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol alongside Obsikon 37.5mg Tablet CR is inadvisable.
PregnancyUNSAFE
Using Obsikon 37.5mg CR tablets during pregnancy poses a serious risk. Pregnant women should consult their physician; research in animals and pregnant women indicates substantial harm to the fetus.
Breast feedingCONSULT YOUR DOCTOR
Prolonged-release Obsikon 37.5mg tablets are likely unsafe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a risk to the infant.
DrivingUNSAFE
Taking Obsikon 37.5mg Controlled-Release Tablets might cause drowsiness, blurred vision, or dizziness. Refrain from driving if you experience these effects.
KidneyCAUTION
Patients with kidney impairment should use Obsikon 37.5mg Controlled-Release tablets cautiously. Dosage modification for Obsikon 37.5mg Controlled-Release tablets may be necessary; physician consultation is advised.
LiverCAUTION
Patients with hepatic impairment should use Obsikon 37.5mg CR tablets cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Obsikon 37.5mg Tablet CR :
Should you forget a dose of your Obsikon 37.5mg Tablet CR, take it immediately. But, if your next dose is nearly due, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Obsikon 37.5mg Tablet CR
| Label | Value |
|---|---|
| Chemical Classification | Piperidine Phenyl Derivative |
| Developing Habits | No. |
| Treatment Category | Neuroscience of the Central Nervous System |
| Action Class | Selective serotonin reuptake inhibitors (SSRIs) |
